PRINCETON, N.J., May 22, 2012 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, announced today that the U.S.

GREENVILLE, S.C., May 22, 2012 /PRNewswire/ -- Glytec, LLC, headquartered in Greenville, SC, announced today that its Glucommander(TM) 2.0 Enterprise software has been cleared by the FDA for

PRINCETON, N.J., April 9, 2012 /PRNewswire/ -- Novo Nordisk received approval from the U.S.

Novo Nordisk now offers its comprehensive line of insulin analog products with a pregnancy Category B classification for use with the FlexPen(®), including Levemir(®) (insulin detemir [rDNA origin] injection) FlexPen(®). FlexPen(®) is a discreet, prefilled insulin pen device that gives patients the ability to manage their diabetes while they're on-the-go. FlexPen(®) is covered on more than 90 percent of insurance plans.

PRINCETON, N.J. and INDIANAPOLIS, Ind., Nov. 15, 2011 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, and Chip Ganassi Racing Teams, Inc.